Inhibition of carboxyethylphosphoramide mustard formation from 4-hydroxycyclophosphamide by carmustine.

about

High exposures to bioactivated cyclophosphamide are related to the occurrence of veno-occlusive disease of the liver following high-dose chemotherapy

P2860

Q36614634-F070A435-957A-4BF7-B7B8-25C4DFD73841

P2860

Inhibition of carboxyethylphosphoramide mustard formation from 4-hydroxycyclophosphamide by carmustine.

Item

http://www.wikidata.org/entity/Q41906647

description

1999 nî lūn-bûn

@nan

1999年の論文

@ja

1999年論文

@yue

1999年論文

@zh-hant

1999年論文

@zh-hk

1999年論文

@zh-mo

1999年論文

@zh-tw

1999年论文

@wuu

1999年论文

@zh

1999年论文

@zh-cn

name

Inhibition of carboxyethylphos ...... yclophosphamide by carmustine.

@en

type

Item

label

Inhibition of carboxyethylphos ...... yclophosphamide by carmustine.

@en

prefLabel

Inhibition of carboxyethylphos ...... yclophosphamide by carmustine.

@en

P1476

Inhibition of carboxyethylphos ...... yclophosphamide by carmustine.

@en

P2093

J T Slatterly

http://www.w3.org/2001/XMLSchema#string

S Ren

http://www.w3.org/2001/XMLSchema#string

P2860

A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding

Studies on cyclophosphamide metabolites and their related compounds. 2. Preparation of an active species of cyclophosphamide and related compounds

Identification of human liver aldehyde dehydrogenases that catalyze the oxidation of aldophosphamide and retinaldehyde.

Hepatic venoocclusive disease in autologous bone marrow transplantation of solid tumors and lymphomas.

Glutathione, cell proliferation, and 1,3-bis-(2-chloroethyl)-1-nitrosourea in K562 leukemia.

Identification of the polymorphically expressed CYP2C19 and the wild-type CYP2C9-ILE359 allele as low-Km catalysts of cyclophosphamide and ifosfamide activation.

Cytosolic aldehyde dehydrogenase (ALDH1) variants found in alcohol flushers.

Cellular target of cyclophosphamide toxicity in the murine liver: role of glutathione and site of metabolic activation.

Enhanced cyclophosphamide and ifosfamide activation in primary human hepatocyte cultures: response to cytochrome P-450 inducers and autoinduction by oxazaphosphorines

P304

E14

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1208/PS010314

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

1999-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

11615883

http://www.w3.org/2001/XMLSchema#string

P698

11741210

http://www.w3.org/2001/XMLSchema#string

P932

2761128

http://www.w3.org/2001/XMLSchema#string

Inhibition of carboxyethylphosphoramide mustard formation from 4-hydroxycyclophosphamide by carmustine.

about

P2860

P2860

Inhibition of carboxyethylphosphoramide mustard formation from 4-hydroxycyclophosphamide by carmustine.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P932